Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

303 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 303 results

Not applicableStudy completedNCT02353715
What this trial is testing

Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing

Who this might be right for
Prostate Cancer
Duke University 38
Testing effectiveness (Phase 2)UnknownNCT02525068
What this trial is testing

Enzalutamide in Combination With AZD5363 in Patients With mCRPC

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 136
Testing effectiveness (Phase 2)Ended earlyNCT02489123
What this trial is testing

Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Ann Arbor Stage I Mantle Cell LymphomaAnn Arbor Stage II Mantle Cell LymphomaAnn Arbor Stage III Mantle Cell Lymphoma+3 more
University of Washington 8
Testing effectiveness (Phase 2)Ended earlyNCT03764540
What this trial is testing

Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide

Who this might be right for
Metastatic Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 57
Testing effectiveness (Phase 2)Looking for participantsNCT07287150
What this trial is testing

Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Hoffmann-La Roche 100
Early research (Phase 1)Study completedNCT01565928
What this trial is testing

Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 23
Testing effectiveness (Phase 2)Study completedNCT02203695
What this trial is testing

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Testing effectiveness (Phase 2)Ended earlyNCT03531827
What this trial is testing

Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Who this might be right for
Metastatic Castration Resistant Prostate CancerProstate Neoplasms
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT02833883
What this trial is testing

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration Resistant Prostate Cancer
Memorial Sloan Kettering Cancer Center 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07802704
What this trial is testing

Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 684
Testing effectiveness (Phase 2)Active Not RecruitingNCT04419402
What this trial is testing

Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 162
Large-scale testing (Phase 3)Study completedNCT02677896
What this trial is testing

Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 1,150
Large-scale testing (Phase 3)Active Not RecruitingNCT02319837
What this trial is testing

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Who this might be right for
Hormone Sensitive Prostate CancerProstate CancerCancer of the Prostate
Pfizer 1,068
Not applicableStudy completedNCT02471469
What this trial is testing

Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Radboud University Medical Center 40
Not applicableStudy completedNCT07086651
What this trial is testing

Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Cancer of the ProstateProstate Neoplasms+1 more
Pfizer 1,300
Testing effectiveness (Phase 2)UnknownNCT04116775
What this trial is testing

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Who this might be right for
Prostate CancerProstate Cancer Metastatic
Julie Graff, MD 32
Testing effectiveness (Phase 2)Study completedNCT02268175
What this trial is testing

Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

Who this might be right for
Prostate AdenocarcinomaProstate CancerHigh Risk Prostate Cancer
Dana-Farber Cancer Institute 75
Testing effectiveness (Phase 2)Ended earlyNCT02607228
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer
Gilead Sciences 31
Early research (Phase 1)Study completedNCT01597193
What this trial is testing

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 101
Testing effectiveness (Phase 2)Looking for participantsNCT04363164
What this trial is testing

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Who this might be right for
Castration Resistant Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 150
Next Page